21. April 2021 | Corporate News

Marinomed Biotech AG announces positive data demonstrating Carragelose efficacy against SARS-CoV-2 variants

Press release

The full press release is available as download here:

Marinomed Biotech AG announces positive data demonstrating Carragelose efficacy against SARS-CoV-2 variants
(156 KB)